Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience

Author： Sabel Michael   Giese Alf  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.24, Iss.11, 2008-11, pp. : 3239-3257

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Trials with Intracerebral Convection-Enhanced Delivery of Targeted Toxins in Malignant Glioma

By  

Reviews on Recent Clinical Trials, Vol. 3, Iss. 1, 2008-01 ,pp. : 2-9

Bentham Science Publishers

Access to resources Recommend Favorite

Carmustine (BCNU) plus Teniposide (VM26) in Recurrent Malignant Glioma

By  

Oncology, Vol. 86, Iss. 5-6, 2014-06 ,pp. : 369-372

Karger

Access to resources Recommend Favorite

The Alexander Technique: A Systematic Review of Controlled Clinical Trials

By  

Forschende Komplementärmedizin / Research in Complementary Medicine, Vol. 10, Iss. 6, 2004-01 ,pp. : 325-329

Karger

Access to resources Recommend Favorite

The Safety of the Temozolomide in Patients with Malignant Glioma

By  

Current Drug Safety, Vol. 1, Iss. 2, 2006-05 ,pp. : 205-222

Bentham Science Publishers

Access to resources Recommend Favorite

Safety profile of topical diclofenac: a meta-analysis of blinded, randomized, controlled trials in musculoskeletal conditions

By Taylor R.S.   Fotopoulos G.   Maibach H.  

Current Medical Research and Opinion, Vol. 27, Iss. 3, 2011-03 ,pp. : 605-622

Informa Healthcare

Access to resources Recommend Favorite